2024-02-16 12:58:16 ET
Summary
- Moderna has become a household name due to its COVID vaccine during the pandemic.
- However, cracks are beginning to show for mRNA vaccines when compared with traditional vaccines.
- As such, I believe Moderna faces significant risks and competition in a post-pandemic world.
Moderna Introduction
Moderna ( MRNA ), who is synonymous with mRNA vaccine, rose to fame during the COVID pandemic as it was able to secure FDA emergency approval of its COVID vaccine Spikevax in less than 11 months. As such it became a Wall Street darling and saw its stock price spiked to ~$500 mid-2021. 2.5 years later today it has fallen 83% to ~$87, as a result of dwindling Spikevax revenue, and uncertainty overall for mRNA vaccine in a post-pandemic world....
Read the full article on Seeking Alpha
For further details see:
Moderna: Highly Uncertain Future For mRNA Vaccine In A Post-Pandemic World